• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Phase III multicenter randomized clinical trial to evaluate the safety and efficacy of CoFactor/5-fluorouracil/bevacizumab versus leucovorin/5-fluorouracil/bevacizumab as initial treatment for metastatic colorectal carcinoma.

作者信息

Saif Muhammad Wasif, Merritt James, Robbins Joan, Stewart Jeffrey, Schupp Joachim

机构信息

Developmental Therapeutics Program, Yale Cancer Center, Yale University School of Medicine, New Haven, CT 06520, USA.

出版信息

Clin Colorectal Cancer. 2006 Sep;6(3):229-34. doi: 10.3816/CCC.2006.n.042.

DOI:10.3816/CCC.2006.n.042
PMID:17026795
Abstract
摘要

相似文献

1
Phase III multicenter randomized clinical trial to evaluate the safety and efficacy of CoFactor/5-fluorouracil/bevacizumab versus leucovorin/5-fluorouracil/bevacizumab as initial treatment for metastatic colorectal carcinoma.一项III期多中心随机临床试验，旨在评估辅酶/5-氟尿嘧啶/贝伐单抗与亚叶酸钙/5-氟尿嘧啶/贝伐单抗作为转移性结直肠癌初始治疗的安全性和有效性。
Clin Colorectal Cancer. 2006 Sep;6(3):229-34. doi: 10.3816/CCC.2006.n.042.
2
Bevacizumab in combination with fluoropyrimidine-based chemotherapy for the first-line treatment of metastatic colorectal cancer.贝伐珠单抗联合氟嘧啶类化疗作为转移性结直肠癌的一线治疗。
Health Technol Assess. 2010 Oct;14(Suppl. 2):47-53. doi: 10.3310/hta14suppl2/07.
3
Bevacizumab in combination with chemotherapy: first-line treatment of patients with metastatic colorectal cancer.贝伐单抗联合化疗：转移性结直肠癌患者的一线治疗
Semin Oncol. 2006 Oct;33(5 Suppl 10):S8-14. doi: 10.1053/j.seminoncol.2006.08.005.
4
[Improving longevity in advanced intestinal cancer].[提高晚期肠癌的生存期]
Krankenpfl J. 2005;43(1-3):48.
5
Phase II multicenter trial of bevacizumab plus fluorouracil and leucovorin in patients with advanced refractory colorectal cancer: an NCI Treatment Referral Center Trial TRC-0301.贝伐单抗联合氟尿嘧啶和亚叶酸钙治疗晚期难治性结直肠癌的II期多中心试验：一项美国国立癌症研究所治疗转诊中心试验TRC-0301
J Clin Oncol. 2006 Jul 20;24(21):3354-60. doi: 10.1200/JCO.2005.05.1573.
6
Commentary on a phase III trial of bevacizumab plus XELOX or FOLFOX4 for first-line treatment of metastatic colorectal cancer: the NO16966 trial.贝伐单抗联合XELOX或FOLFOX4一线治疗转移性结直肠癌的III期试验评论：NO16966试验
Clin Colorectal Cancer. 2006 Nov;6(4):261-4. doi: 10.3816/CCC.2006.n.044.
7
Short time infusion of bevacizumab in combination with 5FU-based chemotherapy as first-line therapy in a non-selective patient group with metastatic colorectal cancer.在一组非选择性转移性结直肠癌患者中，短期输注贝伐单抗联合基于5-氟尿嘧啶的化疗作为一线治疗方案。
Acta Oncol. 2010 Apr;49(3):395-6. doi: 10.3109/02841860903428184.
8
Current role of bevacizumab in colorectal cancer.贝伐单抗在结直肠癌中的当前作用。
Clin Adv Hematol Oncol. 2009 Jun;7(6):375-6.
9
Safety of 10 min infusion of bevacizumab in combination with 5FU-based chemotherapy in non-selected metastatic colorectal cancer patients.在未选择的转移性结直肠癌患者中，贝伐单抗与基于5-氟尿嘧啶的化疗联合输注10分钟的安全性。
Dig Liver Dis. 2011 Mar;43(3):248-9. doi: 10.1016/j.dld.2010.10.013. Epub 2010 Dec 9.
10
Gene expression of vascular endothelial growth factor A, thymidylate synthase, and tissue inhibitor of metalloproteinase 3 in prediction of response to bevacizumab treatment in colorectal cancer patients.血管内皮生长因子 A、胸苷酸合成酶和金属蛋白酶组织抑制剂 3 的基因表达在预测结直肠癌患者贝伐珠单抗治疗反应中的作用。
Dis Colon Rectum. 2011 Aug;54(8):1026-35. doi: 10.1097/DCR.0b013e31821c44af.

引用本文的文献

1
Bevacizumab-Based Chemotherapy Combined with Regional Deep Capacitive Hyperthermia in Metastatic Cancer Patients: A Pilot Study.贝伐单抗联合化疗联合区域深部电容式热疗治疗转移性癌症患者的初步研究。
Int J Mol Sci. 2017 Jul 6;18(7):1458. doi: 10.3390/ijms18071458.
2
Evidence for the role of bevacizumab in the treatment of advanced metastatic breast cancer: a review.贝伐珠单抗在晚期转移性乳腺癌治疗中的作用证据：综述。
Breast Cancer (Dove Med Press). 2010 Jun 21;2:37-44. doi: 10.2147/bctt.s6511.
3
Brain microischemic phenomena in a woman receiving bevacizumab treatment: a case report.
一名接受贝伐单抗治疗的女性出现脑微缺血现象：病例报告
J Med Case Rep. 2011 Feb 27;5:84. doi: 10.1186/1752-1947-5-84.